Eledon Pharmaceuticals (ELDN) Operating Leases (2019 - 2026)
Eledon Pharmaceuticals (ELDN) reported Operating Leases of $186000.0 for Q1 2026, down 66.49% on a YoY basis from $555000.0 in Q1 2025, and down 34.28% quarter-over-quarter from $283000.0 in Q4 2025.
Eledon Pharmaceuticals (ELDN) Operating Leases (2019 - 2026) Analysis & Trends
Eledon Pharmaceuticals has reported Operating Leases for 8 years, with the latest figure at $186000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 66.49% year-over-year to $186000.0; the trailing twelve-month figure through Mar 2026 stood at $186000.0 (down 66.49% YoY), and the FY2025 full-year result was $283000.0, down 55.78% from the prior year.
- Operating Leases for Q1 2026 stood at $186000.0, down from $283000.0 in the prior quarter.
- The five-year high for Operating Leases was $640000.0 in Q4 2024, with the low at $83000.0 in Q3 2023.
- Historically, Operating Leases has averaged $350133.3 across 5 years, with a median of $350000.0 in 2022.
- Annual changes were most pronounced in 2022 — Operating Leases surged 924.44% — and 2023, when it slumped 82.0%.
- Eledon Pharmaceuticals' Operating Leases stood at $383000.0 in 2022, then slumped by 78.33% to $83000.0 in 2023, then soared by 671.08% to $640000.0 in 2024, then plunged by 55.78% to $283000.0 in 2025, then plunged by 34.28% to $186000.0 in 2026.
- The last three Operating Leases figures came in at $186000.0 (Q1 2026), $283000.0 (Q4 2025), and $376000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Eledon Pharmaceuticals | 439.58 Mn | 223.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186,000.00 |
| Dec 31, 2025 | 283,000.00 |
| Sep 30, 2025 | 376,000.00 |
| Jun 30, 2025 | 467,000.00 |
| Mar 31, 2025 | 555,000.00 |
| Dec 31, 2024 | 640,000.00 |
| Sep 30, 2024 | 315,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Jun 30, 2023 | 184,000.00 |
| Mar 31, 2023 | 284,000.00 |
| Dec 31, 2022 | 383,000.00 |
| Sep 30, 2022 | 461,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 350,000.00 |
| Dec 31, 2021 | 400,000.00 |
| Sep 30, 2021 | 45,000.00 |
| Jun 30, 2021 | 90,000.00 |
| Jun 30, 2020 | 48,000.00 |
| Mar 31, 2020 | 97,000.00 |